Human Thyroid Cancer Tissue Lysates

Pricing
Normal Lysates:  $125/100 ug
Tumor Lysates:   $175/100 ug
Nor./Tum. set: $270.00 (10% off)
Discounts
2-8    Vials  10%
9-20  Vials  15%
>20   Vials  20%

Call, Fax, or Email Your Order!

Introduction:

Histologic types of thyroid cancer include the following:
Cell type is an important determinant of prognosis in thyroid cancer. There are 4 main varieties of thyroid cancer (although, for clinical management of the patient, thyroid cancer is generally divided into 2 categories, well differentiated or poorly differentiated).
Papillary carcinoma - Papillary/follicular carcinoma.
Follicular carcinoma - Hürthle cell carcinoma.
Medullary carcinoma.
Anaplastic carcinoma - Small cell carcinoma, Giant cell carcinoma.
Others - Lymphoma, Sarcoma, Carcinosarcoma.

Human Thyroid Cancer Lysates

Catalog Number

Diagnosis

Grade

Stage

TNM

Sex

Age

T16-001

Papillary carcinoma

n/a

n/a

n/a

M

n/a

T16-002

Thyroid carcinoma

n/a

n/a

n/a

F

n/a

T16-003

Follicular carcinoma

n/a

III

T3N1bM0

F

14

T16-004

Medullary carcinoma

n/a

n/a

n/a

F

5

T16-005

Papillary carcinoma

n/a

n/a

n/a

F

49

T16-006

Papillary adenocarcinoma

n/a

III

T2N1M0

F

53

T16-007

Papillary carcinoma

n/a

III

T3N1M0

F

30

T16-008

Benign colloid nodules

n/a

n/a

n/a

F

72

T16-009

Papillary carcinoma

1

n/a

T2N1aM0

F

18

T16-010

Papillary carcinoma

n/a

III

T3N1M0

M

25

T16-011

Papillary carcinoma

n/a

II

T2N1M0

M

39

T16-012

Papillary cystadenocarcinoma

n/a

n/a

T1bNxM0

F

46

T16-013

Papillary carcinoma

n/a

II

T2N1M0

M

42

T16-014

Papillary carcinoma

n/a

n/a

n/a

F

38

T16-015

Papillary carcinoma

1

n/a

n/a

F

58

T16-016

Papillary carcinoma

1

I

T1N0Mx

M

64

T16-017

Adenocystic carcinoma

2

IIB

T2N1M0

M

67

T16-018

Papillary adenocystic carcinoma

n/a

II

T2N1M0

F

32

T16-019

Papillary carcinoma

1

n/a

n/a

F

73

T16-020

Papillary carcinoma

1

II

n/a

F

66

T16-021

Papillary carcinoma

1

II

n/a

M

21

T16-022

Papillary carcinoma

1

1

n/a

F

22

T16-023

Papillary carcinoma

1

II

T2N0Mx

F

46

T16-024

Medullary carcinoma

2

III

T3N1Mx

F

38

T16-025

Medullary carcinoma

2

n/a

n/a

F

56

T16-026

Thyroid carcinoma

2

II

T2N0Mx

F

49

T16-027

Medullary carcinoma

2

III

T2N1Mx

F

21

T16-028

Papillary carcinoma

1

1

T1N0Mx

F

35

T16-029

Papillary carcinoma

1

II

T2N0Mx

F

22

T16-030

Papillary carcinoma

1

II

T2N0Mx

F

70

T16-031

Papillary carcinoma

1

II

T2N0Mx

M

56

T16-032

Papillary carcinoma

1

II

T2N0Mx

F

44

T16-033

Papillary carcinoma

2

III

T2N1M0

F

24

T16-034

Papillary carcinoma

n/a

III

T3N1M0

F

38

T16-035

Thyroid carcinoma

n/a

n/a

n/a

M

32

 

References:

Mostofi FK, Davis CJ, Sesterhenn IA: Pathology of tumors of the urinary tract. In: Skinner DG, Lieskovsky G, eds.: Diagnosis and Management of Genitourinary Cancer. Philadelphia, Pa: WB Saunders, 1988., pp 83-117.

Wilson TG, Pritchett TR, Lieskovsky G, et al.: Primary adenocarcinoma of bladder. Urology 38 (3): 223-6, 1991.

LiVolsi VA: Pathology of thyroid disease. In: Falk SA: Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy. Philadelphia, PA: Lippincott-Raven, 1997., pp 127-175.